IMCD N.V., founded in 1995 and headquartered in Rotterdam, Netherlands, is a leading global distributor of specialty chemicals and food ingredients. The company operates with the purpose of providing tailored solutions and services to its customers across various industries, including pharmaceuticals, food, and personal care, through an extensive portfolio of innovative products.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| IMCDNA 2.13% 2027-03-31 EURIMCD N.V. | Netherlands | 2027-03-31 | 2.125 | 2.86 |
| IMCDNA 2.50% 2025-03-26 EURIMCD N.V. | Netherlands | 2025-03-26 | 2.500 | 0.00 |
| IMCDNA 4.88% 2028-09-18 EURIMCD N.V. | Netherlands | 2028-09-18 | 4.875 | 3.00 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
IMCD N.V. began issuing bonds in 2015 as part of its strategic funding initiatives to support growth and acquisitions. One notable issuance occurred in 2021, when the company launched a €500 million bond to refinance existing debt and enhance capital structure, achieving significant investor interest reflected in a yield of approximately 1.5%, which is competitive compared to industry averages. This bond included a green finance component, aligning with IMCD's commitment to sustainability, and has been well-received by the market, further strengthening investor confidence in the company’s financial stability.